![Chang Rung Chen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Chang Rung Chen was the founder of Processa Pharmaceuticals, Inc. (founded in 2011) where he held the title of Senior Director-Translational Science until 2022.
He also held the position of Director-Bimolecular Discovery at ArQule, Inc. and Director-Translational Research & Pharmacology at Questcor Pharmaceuticals, Inc. from 2015 to 2016.
Dr. Chen received his graduate and doctorate degrees from New York University and his undergraduate degree from Tunghai University.
Antiguos cargos conocidos de Chang Rung Chen.
| Empresas | Cargo | Fin |
|---|---|---|
| PROCESSA PHARMACEUTICALS, INC. | Fundador | 01/11/2022 |
| QUESTCOR PHARMACEUTICALS INC | Corporate Officer/Principal | 01/01/2016 |
| ARQULE, INC. | Corporate Officer/Principal | - |
Formación de Chang Rung Chen.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
15
Relaciones de 1er grado
5
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
Questcor Pharmaceuticals, Inc.
 Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, markets and sells prescription drugs | Health Technology |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tunghai University
 Tunghai University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Processa Pharmaceuticals, Inc.
 Processa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products | Health Technology |
- Bolsa de valores
- Insiders
- Chang Rung Chen
